Inflammatory myopathy associated with PD-1 inhibitors
- 10 March 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 100, 105-113
- https://doi.org/10.1016/j.jaut.2019.03.005
Abstract
No abstract availableKeywords
Funding Information
- JSPC KAKENHI (JP17K09784)
- Intramural Research (29-4)
- Ministry of Health, Labour and Welfare of Japan
This publication has 40 references indexed in Scilit:
- High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibodyBrain, 2016
- Pembrolizumab-induced necrotic myositis in a patient with metastatic melanomaAnnals of Oncology, 2016
- Management of toxicities of immune checkpoint inhibitorsCancer Treatment Reviews, 2016
- The future of immune checkpoint therapyScience, 2015
- Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathiesJournal of Neuroimmunology, 2014
- Super high resolution for single molecule‐sequence‐based typing of classical HLA loci at the 8‐digit level using next generation sequencersTissue Antigens, 2012
- Clinical and immunological differences between early and late-onset myasthenia gravis in JapanJournal of Neuroimmunology, 2011
- Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia GravisArchives of Neurology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- MYASTHENIA GRAVIS IMMUNOLOGICAL RELATIONSHIP BETWEEN STRIATED MUSCLE AND THYMUSThe Lancet, 1966